Alpine Immune Sciences Alpha and Beta Analysis
| ALPNDelisted Stock | USD 12.37 0.23 1.83% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Alpine Immune Sciences. It also helps investors analyze the systematic and unsystematic risks associated with investing in Alpine Immune over a specified time horizon. Remember, high Alpine Immune's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Alpine Immune's market risk premium analysis include:
Beta 0.11 | Alpha 0.81 | Risk 0.0 | Sharpe Ratio 0.0 | Expected Return 0.0 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Alpine |
Alpine Immune Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Alpine Immune market risk premium is the additional return an investor will receive from holding Alpine Immune long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Alpine Immune. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Alpine Immune's performance over market.| α | 0.81 | β | 0.11 |
Alpine Immune Fundamentals Vs Peers
Comparing Alpine Immune's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Alpine Immune's direct or indirect competition across all of the common fundamentals between Alpine Immune and the related equities. This way, we can detect undervalued stocks with similar characteristics as Alpine Immune or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Alpine Immune's fundamental indicators could also be used in its relative valuation, which is a method of valuing Alpine Immune by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Alpine Immune to competition |
| Fundamentals | Alpine Immune | Peer Average |
| Return On Equity | -0.15 | -0.31 |
| Return On Asset | -0.1 | -0.14 |
| Profit Margin | (0.65) % | (1.27) % |
| Operating Margin | (3.23) % | (5.51) % |
| Current Valuation | 4.16 B | 16.62 B |
| Shares Outstanding | 68.6 M | 571.82 M |
| Shares Owned By Insiders | 4.60 % | 10.09 % |
Alpine Immune Opportunities
Alpine Immune Return and Market Media
The Stock did not receive any noticable media coverage during the period. Price Growth (%) |
| Timeline |
About Alpine Immune Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Alpine or other delisted stocks. Alpha measures the amount that position in Alpine Immune Sciences has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Alpine Immune Upcoming Company Events
As portrayed in its financial statements, the presentation of Alpine Immune's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Alpine Immune's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Alpine Immune's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Alpine Immune. Please utilize our Beneish M Score to check the likelihood of Alpine Immune's management manipulating its earnings.
| 28th of March 2024 Upcoming Quarterly Report | View | |
| 9th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 28th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Alpine Immune
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Other Consideration for investing in Alpine Stock
If you are still planning to invest in Alpine Immune Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Alpine Immune's history and understand the potential risks before investing.
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |